Last reviewed · How we verify
ESTROGEN HERBALS 21
ESTROGEN HERBALS 21 is a Small molecule drug developed by Trieu, Nguyen Thi, M.D.. It is currently FDA-approved. Also known as: EPGANA 21.
Estrogen Herbals 21, marketed by Trieu, Nguyen Thi, M.D., is an herbal product currently available in the market. The key composition patent is set to expire in 2028, providing a period of exclusivity that may help maintain market position. The primary risk is the lack of clear primary indication and revenue data, which could limit its competitive edge and investor confidence.
At a glance
| Generic name | ESTROGEN HERBALS 21 |
|---|---|
| Also known as | EPGANA 21 |
| Sponsor | Trieu, Nguyen Thi, M.D. |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- ESTROGEN HERBALS 21 CI brief — competitive landscape report
- ESTROGEN HERBALS 21 updates RSS · CI watch RSS
- Trieu, Nguyen Thi, M.D. portfolio CI
Frequently asked questions about ESTROGEN HERBALS 21
What is ESTROGEN HERBALS 21?
Who makes ESTROGEN HERBALS 21?
Is ESTROGEN HERBALS 21 also known as anything else?
What development phase is ESTROGEN HERBALS 21 in?
Related
- Manufacturer: Trieu, Nguyen Thi, M.D. — full pipeline
- Also known as: EPGANA 21